Double Medical Technology Inc (002901) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.060x

Based on the latest financial reports, Double Medical Technology Inc (002901) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥207.34 Million ≈ $30.34 Million USD) by net assets (CN¥3.44 Billion ≈ $503.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Double Medical Technology Inc (002901) market capitalisation for the company's overall valuation and market capitalisation.

Double Medical Technology Inc - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Double Medical Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Double Medical Technology Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Double Medical Technology Inc ranked by their cash flow conversion efficiency. Explore 002901 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
FOCI Fiber Optic Communications
TWO:3363
0.036x
AstraZeneca PLC
LSE:AZN
0.057x
Electra Ltd
TA:ELTR
0.046x
Zhejiang XinAn Chemical Industrial Group Co Ltd
SHG:600596
0.018x
Wallenstam AB (publ)
ST:WALL-B
0.011x
Suzhou Hesheng Special Material Co Ltd
SHE:002290
0.079x
Penn National Gaming Inc
NASDAQ:PENN
0.130x
Guangxi Guitang Group Co Ltd
SHE:000833
0.058x

Annual Cash Flow Conversion Efficiency for Double Medical Technology Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Double Medical Technology Inc from 2013 to 2025. View Double Medical Technology Inc (002901) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.69 Billion
≈ $539.27 Million
CN¥831.34 Million
≈ $121.65 Million
0.226x +62.27%
2024-12-31 CN¥3.18 Billion
≈ $465.57 Million
CN¥442.30 Million
≈ $64.72 Million
0.139x +494.63%
2023-12-31 CN¥3.16 Billion
≈ $462.50 Million
CN¥73.89 Million
≈ $10.81 Million
0.023x -43.46%
2022-12-31 CN¥3.11 Billion
≈ $454.56 Million
CN¥128.44 Million
≈ $18.80 Million
0.041x -84.10%
2021-12-31 CN¥2.59 Billion
≈ $378.76 Million
CN¥673.26 Million
≈ $98.52 Million
0.260x -0.13%
2020-12-31 CN¥2.13 Billion
≈ $312.26 Million
CN¥555.77 Million
≈ $81.33 Million
0.260x +5.26%
2019-12-31 CN¥1.75 Billion
≈ $256.59 Million
CN¥433.88 Million
≈ $63.49 Million
0.247x +7.72%
2018-12-31 CN¥1.46 Billion
≈ $213.33 Million
CN¥334.88 Million
≈ $49.00 Million
0.230x -7.84%
2017-12-31 CN¥1.24 Billion
≈ $181.24 Million
CN¥308.70 Million
≈ $45.17 Million
0.249x -30.19%
2016-12-31 CN¥580.13 Million
≈ $84.89 Million
CN¥207.13 Million
≈ $30.31 Million
0.357x +27.78%
2015-12-31 CN¥441.78 Million
≈ $64.65 Million
CN¥123.44 Million
≈ $18.06 Million
0.279x -49.27%
2014-12-31 CN¥274.36 Million
≈ $40.15 Million
CN¥151.12 Million
≈ $22.11 Million
0.551x +16.16%
2013-12-31 CN¥224.61 Million
≈ $32.87 Million
CN¥106.51 Million
≈ $15.59 Million
0.474x --

About Double Medical Technology Inc

SHE:002901 China Medical Devices
Market Cap
$2.34 Billion
CN¥16.02 Billion CNY
Market Cap Rank
#5642 Global
#1038 in China
Share Price
CN¥38.69
Change (1 day)
+0.03%
52-Week Range
CN¥38.68 - CN¥59.00
All Time High
CN¥114.55
About

Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying J… Read more